Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 91–120 of 577 companies · sorted by market cap (high to low)
254 covered companies have no sector on record (3IN.L, AAF.L, AAL.L, ABDN.L, ABF.L, ADM.L, AEP.L, AJB.L, ALFA.L, AML.L, ANTO.L, AO.L), so they were not tested by this filter — a gap in our sector data, not evidence they do not belong here.
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| GKOS | GLAUKOS CORP | Health Care | $177.47 | $10.5B | n/a | +41.5% | -37.0% | n/a | +96.9% |
| UHS | Universal Health Services | Health Care | $169.65 | $10.4B | 6.9 | +10.1% | +8.6% | +0.6% | -8.6% |
| PODD | Insulet Corporation | Health Care | $147.48 | $10.2B | 27.6 | +29.4% | +9.1% | n/a | -57.4% |
| AVTR | Avantor | Health Care | $14.97 | $10.2B | n/a | -1.6% | -8.1% | n/a | +13.5% |
| APGE | APOGEE THERAPEUTICS INC | Health Care | $135.07 | $10.2B | n/a | n/a | n/a | n/a | +263.8% |
| CYTK | CYTOKINETICS INC | Health Care | $72.72 | $10.1B | n/a | -21.1% | -891.6% | n/a | +46.2% |
| HSIC | Henry Schein | Health Care | $89.81 | $10.0B | 26.2 | +6.5% | +3.0% | n/a | +32.5% |
| PRAX | PRAXIS PRECISION MEDICINES INC | Health Care | $351.81 | $9.8B | n/a | n/a | n/a | n/a | +663.3% |
| TEM | Tempus AI | Health Care | $64.62 | $9.8B | n/a | +50.4% | -19.3% | n/a | -17.3% |
| NUVL | NUVALENT INC CLASS A | Health Care | $123.96 | $9.8B | n/a | n/a | n/a | n/a | +50.3% |
| KYMR | KYMERA THERAPEUTICS INC | Health Care | $117.39 | $9.8B | n/a | n/a | -794.0% | n/a | +178.2% |
| IONS | Ionis Pharmaceuticals | Health Care | $58.09 | $9.7B | n/a | -7.5% | -40.4% | n/a | -2.1% |
| RGEN | Repligen | Health Care | $167.60 | $9.5B | 228.4 | +16.5% | n/a | n/a | +39.0% |
| PTGX | PROTAGONIST THERAPEUTICS INC | Health Care | $145.72 | $9.4B | 140.5 | +34.8% | n/a | n/a | +144.5% |
| PCVX | VAXCYTE INC | Health Care | $61.16 | $9.1B | n/a | n/a | n/a | n/a | +90.2% |
| CRNX | CRINETICS PHARMACEUTICALS INC | Health Care | $84.95 | $9.0B | n/a | n/a | -6046.2% | n/a | +155.1% |
| QGEN | Qiagen | Health Care | $43.47 | $8.9B | 23.0 | +4.8% | +20.3% | n/a | -7.6% |
| BRKR | Bruker | Health Care | $58.50 | $8.9B | n/a | +1.6% | -0.3% | +0.3% | +96.4% |
| TGTX | TG THERAPEUTICS INC | Health Care | $55.99 | $8.6B | 20.4 | +76.1% | +72.6% | n/a | +75.6% |
| IBRX | IMMUNITYBIO INC | Health Care | $8.08 | $8.6B | n/a | +192.9% | -310.2% | n/a | +238.1% |
| IMVT | IMMUNOVANT INC | Health Care | $39.25 | $8.1B | n/a | n/a | n/a | n/a | +143.5% |
| HQY | HEALTHEQUITY INC | Health Care | $96.07 | $7.9B | 36.0 | +7.6% | +16.4% | n/a | -1.7% |
| SYRE | SPYRE THERAPEUTICS INC | Health Care | $88.98 | $7.8B | n/a | n/a | n/a | n/a | +423.7% |
| TWST | TWIST BIOSCIENCE CORP | Health Care | $124.72 | $7.8B | n/a | +19.2% | n/a | n/a | +386.6% |
| ALKS | ALKERMES | Health Care | $46.10 | $7.7B | 119.8 | +10.8% | +16.4% | n/a | +59.4% |
| TXG | 10X GENOMICS INC CLASS A | Health Care | $62.65 | $7.6B | n/a | -4.3% | -6.8% | n/a | +361.7% |
| CAI | Caris Life Sciences | Health Care | $25.07 | $7.1B | 68.3 | +38.5% | -8.4% | n/a | -31.0% |
| RYTM | RHYTHM PHARMACEUTICALS INC | Health Care | $102.74 | $7.1B | n/a | +53.5% | -103.6% | n/a | -1.8% |
| HNGE | HINGE HEALTH INC CLASS A | Health Care | $92.37 | $7.1B | n/a | +47.2% | -89.9% | n/a | +64.9% |
| CHE | Chemed Corporation | Health Care | $519.84 | $6.8B | 26.1 | +3.3% | +10.5% | +0.3% | +13.1% |
Every view here has its own address — copy the link from your browser to share exactly what you are looking at. Click a column header to sort.
Data: SEC EDGAR (filings) + market data (prices, fundamentals). Prices on this page are from the 2026-07-21 close or later — each figure is labelled with its own as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date. Past performance does not indicate future results.